Brief: SPAC Backed By Corvex, Casdin Near Deal For Drug-Price Startup EQRx - WSJ
06/08/2021 11:07
Aug 6 (Reuters) - CM Life Sciences III Inc CMLT.O :
* SPAC BACKED BY CORVEX, CASDIN NEAR DEAL FOR DRUG-PRICE
STARTUP
EQRX - WSJ
* THE DEAL INCLUDES A $1.2 BILLION INVESTMENT FROM A
SUBSIDIARY OF
SOFTBANK, AMONG OTHERS - WSJ
Further company coverage: CMLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EQRx
See all newsBrief: Leading Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Revolution Medicines Stockholders Vote "FOR" Proposed Acquisition Of EQRx, Inc
Brief: Revolution Medicines Inc Says Will Acquire EQRx In An All-Stock Transaction
U.S. RESEARCH ROUNDUP- Cigna Group, McKesson, Zscaler
Brief: EQRx posts Q1 EPS USD -0.17
Brief: EQRx Says Jami Rubin Will Step Down As Chief Financial Officer